Active substance
Results for the substance selpercatinib
4 results
About this active substance
Selpercatinib is a medication used for the treatment of certain types of cancer, such as non-small cell lung cancer (NSCLC) and thyroid cancer, that have RET gene mutations or fusions. It acts as a RET kinase inhibitor, blocking signaling that promotes tumor growth.
The medication is taken orally, as directed by a doctor, usually twice daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as diarrhea, elevated liver enzyme levels, or high blood pressure. It is important to inform the doctor of any unusual symptoms.
Common side effects include diarrhea, elevated liver enzyme levels, and high blood pressure. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, as directed by a doctor, usually twice daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as diarrhea, elevated liver enzyme levels, or high blood pressure. It is important to inform the doctor of any unusual symptoms.
Common side effects include diarrhea, elevated liver enzyme levels, and high blood pressure. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
-
-
RETSEVMO 40mg film-coated tablets ELI LILLY ORIGINAL MEDICINE
-
RETSEVMO 40mg capsules ELI LILLY ORIGINAL MEDICINE
-
RETSEVMO 80mg capsules ELI LILLY ORIGINAL MEDICINE